(Fleeger, 1993 WHO, 1992 British Pharmacopoeia Commission,ġ.2 Group ATC classification index Cardiac therapy (C01)/ Antiarrhythmics, Class 1Aġ.3 Synonyms Amidoprocain Novocamid Novocainamid Novocainamide Novocainamidum Novocaine amide Procaine amide Procaine amide hydrochloride Procainamidi Chloridum Procainamidi Hydrochloridum p-Aminobenzoic diethylaminoethylamide NAME 1.1 Substance Procainamide (INN, 1992 BAN, 1994)
AUTHOR(S), REVIEWER(S), DATE(S) (INCLUDING UPDATES), COMPLETE ADDRESS(ES)ġ. NAMEĢ.4 First aid measures and management principlesģ.3.2 Properties of the locally available formulation(s)ģ.4.2 Shelf-life of the locally available formulation(s)ģ.4.5 Specific properties and compositionĦ.3 Biological half-life by route of exposureĩ.4 Systematic description of clinical effectsĩ.4.9 Eye, ear, nose, throat: local effectsĩ.4.12.2 Fluid and electrolyte disturbancesġ0.3 Life supportive procedures and symptomatic/specific treatmentġ4.
0 kommentar(er)
